Cheat sheet
DHA Pharmacist Exam Cheat Sheet
Toxicology
- Not published of exam
- Antidotes Toxidromes Decontamination Overdose Triage
Medicinal Chemistry
- Not published of exam
- Structure Activity Ionization Antimicrobials Stereochemistry
Sterile & Nonsterile Compounding
- Not published of exam
- Aseptic Technique Sterile Preparations Nonsterile Methods Compatibility
Pharmaceutics & Biopharmaceutics
- Not published of exam
- Dosage Forms BCS Classes Dissolution Modified Release
Pharmacognosy & Dietary Supplements
- Not published of exam
- Herb Interactions Supplement Safety Natural Products Patient Disclosure
Pharmacy Calculations & Compounding
- Not published of exam
- Concentrations Dose Calculations Infusion Rates Renal Estimates
Clinical Pharmacogenomics
- Not published of exam
- Gene Drug Pairs Metabolizer Status HLA Risk Dose Selection
Infection Control
- Not published of exam
- Hand Hygiene Injection Safety Sharps Clean Preparation
Pharmacokinetics
- Not published of exam
- ADME Half-Life Clearance Distribution
Pharmaceutical Care & Disease Management
- Not published of exam
- Medication Review Disease Management Counseling Monitoring
Medication Safety
- Not published of exam
- Five Rights Reconciliation High Alert Error Prevention
Over-the-Counter Medication
- Not published of exam
- Self Care Triage Red Flags Referral Product Selection
Pharmacy Law & Ethics
- Not published of exam
- UAE Pharmacy Law Confidentiality Controlled Medicines Professional Ethics
Clinical Pharmacology & Therapeutic Decisions
- Not published of exam
- Receptors Dose Response Interactions Therapeutic Choices
Quick Facts
- Exam DHA Pharmacist PHO5481
- Authority Dubai Health Authority
- Delivery Prometric CBT
- Format Multiple-choice questions
- Questions 150 questions
- Duration 3 hours
- Pass Score 60%
- Assessment Fee USD 240
- Result Pass/Fail; score withheld
- Coverage Areas 14 published topics
- Domain Weights Not published
- Attempt Limit Three across UAE authorities
- Retake Wait No DHA grace period
- Licensing Portal Sheryan
Poisoning Response Picker TO
- Patient unstable → ABCs first ( Activate emergency response )
- Exposure suspected → Toxicology guidance ( Contact local service )
- History available → Agent-dose-time ( Include formulation )
- Initial assessment → Vitals, ECG, glucose ( Check temperature )
- Unknown ingestion → Supportive care ( Avoid blind antidotes )
- Decontamination considered → Toxicology protocol ( Never induce emesis )
- Specific indication → Appropriate antidote ( Check contraindications )
- Symptoms improve → Continue monitoring ( Watch delayed toxicity )
Antidote Map TO
- Paracetamol N-acetylcysteine
- Opioids Naloxone
- Organophosphates Atropine + pralidoxime
- TCA cardiotoxicity Sodium bicarbonate
- Methanol/ethylene glycol Fomepizole
- Iron Deferoxamine
- Digoxin Digoxin immune Fab
- Heparin Protamine sulfate
- Warfarin Vitamin K; PCC for emergencies
- Methemoglobinemia Methylene blue; check G6PD
Toxidromes & First Response TO
- Opioid toxidrome Miosis, respiratory depression, coma
- Anticholinergic Hot, dry, dilated, delirious
- Cholinergic Secretions, bradycardia, bronchospasm
- Sympathomimetic Agitation, diaphoresis, tachycardia
- Serotonin syndrome Clonus, hyperreflexia, hyperthermia
- Neuroleptic malignant syndrome Rigidity, hyporeflexia, hyperthermia
- First priority ABCs and emergency support
- Activated charcoal Selected early ingestions
- Induced emesis Never routine
- Poison guidance Contact local toxicology service
Structure-Activity Clues ME
- pKa Ionization depends on environmental pH
- Unionized drug Crosses lipid membranes more readily
- Lipophilicity Often increases membrane penetration
- Beta-lactam ring Binds PBPs; blocks cross-linking
- Sulfonamides PABA pathway antagonists
- Fluoroquinolones Inhibit gyrase/topoisomerase IV
- Macrolides Bind bacterial 50S ribosome
- Aminoglycosides Bind bacterial 30S ribosome
- Stereoisomers Configuration may change activity
- Prodrug Activation creates active moiety
Sterile vs Nonsterile Compounding CO
Sterile
- Aseptic environment required
- Critical sites protected
Nonsterile
- Clean technique required
- Uniformity remains essential
- Route drives sterility need
Compounding Essentials CO
- Aseptic technique Prevents microbial contamination
- Critical site Never touch or obstruct
- HEPA filter Removes airborne particles
- Unidirectional airflow Sweeps contaminants away
- LAFW Nonhazardous product protection
- BSC Hazardous sterile product containment
- Geometric dilution Incrementally mixes unequal amounts
- Levigation Smooths powder with liquid
- Trituration Grinds and mixes powders
- Aliquot method Measures tiny quantities indirectly
- Eutectic pair May liquefy when mixed
- Final label Strength, route, storage, BUD
Pharmaceutics Essentials PH
- BCS Class I High solubility, high permeability
- BCS Class II Low solubility, high permeability
- BCS Class III High solubility, low permeability
- BCS Class IV Low solubility, low permeability
- Smaller particles Usually dissolve faster
- Higher surface area Usually accelerates dissolution
- Enteric coating Delays release until intestine
- Modified release Avoid crushing unless approved
- Suspension Shake before measuring
- Emulsion Two immiscible liquid phases
- Surfactant Lowers interfacial tension
- First-pass effect Lowers systemic bioavailability
Supplement Interaction Flags PH
- St John's wort Induces CYP3A4 and P-gp
- Ginkgo May increase bleeding
- Garlic supplements May increase bleeding
- Ginseng May lower glucose
- Licorice May raise BP, lower potassium
- Kava Hepatotoxicity and sedation concern
- Valerian May add sedation
- Grapefruit Inhibits intestinal CYP3A4
- Natural label Does not guarantee safety
- Supplement history Ask product, dose, frequency
- Interaction action Check before recommending
- Pregnancy Avoid unverified herbal products
Calculation Safety CA
- Units first, estimate, calculate, verify
- Align units Estimate answer Calculate once Verify plausibility
Calculation Picker CA
- Need dose volume → Dose / concentration ( Align units first )
- Need dilution volume → C1V1 = C2V2 ( Same concentration units )
- Weight-based order → mg/kg × kg ( Check dose maximum )
- BSA-based order → mg/m² × BSA ( Verify BSA units )
- Pump infusion → mL / hours ( Convert time first )
- Gravity infusion → Drops/min formula ( Use tubing factor )
- Need rapid target → Loading dose ( Driven by Vd )
- Need ongoing exposure → Maintenance dose ( Driven by clearance )
Calculation Formulae CA
- Dose volume Ordered dose / concentration
- C1V1 = C2V2 Dilution equation
- % w/v Grams per 100 mL
- % v/v Milliliters per 100 mL
- 1:x w/v One gram per x mL
- mg/kg dose Dose factor × weight
- BSA dose mg/m² × BSA
- Infusion rate Volume / hours
- Drops/min Volume × drop factor / minutes
- Quantity dispensed Dose × frequency × days
- Loading dose Target concentration × Vd / F
- Maintenance rate Target concentration × clearance / F
- Cockcroft-Gault (140−age) × kg / (72 × SCr)
- Female CG factor Multiply estimate by 0.85
- Dimensional analysis Cancel units before calculating
- Final check Units, plausibility, rounding
Gene-Drug Pairs PH
- CYP2C19 poor metabolizer Reduced clopidogrel activation
- HLA-B*57:01 Abacavir hypersensitivity risk
- HLA-B*15:02 Carbamazepine SJS/TEN risk
- TPMT/NUDT15 Thiopurine myelotoxicity risk
- DPYD variant Fluoropyrimidine toxicity risk
- UGT1A1 reduced function Irinotecan toxicity risk
- CYP2D6 ultrarapid Codeine toxicity risk
- CYP2D6 poor Reduced codeine activation
- SLCO1B1 variant Statin myopathy risk
- VKORC1/CYP2C9 Warfarin dose sensitivity
- Genotype result Interpret with phenotype
- Clinical action Follow current prescribing guidance
Infection Control Essentials IN
- Before aseptic task Perform hand hygiene
- Visible soil Use soap and water
- Clean hands Alcohol rub often preferred
- Gloves Never replace hand hygiene
- Preparation area Keep designated and clean
- Single-dose vial One patient only
- Needle and syringe One patient, one use
- Every vial entry Use new needle and syringe
- Vial septum Disinfect before entry
- Multidose vial Dedicate when possible
- Used sharps Discard immediately
- Insulin pen One patient only
ADME PH
- Absorb, distribute, metabolize, eliminate
- A = absorption D = distribution M = metabolism E = elimination
Loading vs Maintenance Dose PH
Loading
- Reaches target quickly
- Driven mainly by Vd
Maintenance
- Replaces eliminated drug
- Driven mainly by clearance
- Vd loads; clearance maintains
Pharmacokinetic Core PH
- Absorption Entry into systemic circulation
- Bioavailability F Systemically available fraction
- Vd Amount in body / concentration
- Clearance Elimination rate / concentration
- Half-life 0.693 × Vd / clearance
- Steady state Usually four to five half-lives
- Loading dose driver Volume of distribution
- Maintenance dose driver Clearance
- First-order elimination Constant fraction per time
- Zero-order elimination Constant amount per time
- Enzyme induction Often lowers substrate exposure
- Enzyme inhibition Often raises substrate exposure
- Renal impairment Often reduces drug clearance
PK Dose Drivers PH
- Volume loads; clearance maintains
- Loading = Vd Maintenance = clearance Half-life uses both
First-Order vs Zero-Order PH
First-Order
- Constant fraction eliminated
- Half-life usually constant
Zero-Order
- Constant amount eliminated
- Pathway capacity saturated
- Fraction versus amount
IESA Medication Review PH
- Indication, effectiveness, safety, adherence
- I = needed E = working S = safe A = taken
Pharmaceutical Care Review PH
- Unnecessary therapy No valid indication
- Additional therapy Untreated condition or prevention
- Ineffective therapy Wrong medicine or formulation
- Dose too low Insufficient exposure or frequency
- Adverse reaction Medicine causes harmful response
- Dose too high Excess exposure or frequency
- Nonadherence Regimen not followed
- Interaction screen Drug, food, disease
- Renal function Adjust medicine and interval
- Treatment goal Define measurable patient outcome
- Teach-back Confirms patient understanding
- Follow-up Reassess outcome and safety
Five Rights ME
- Patient, drug, dose, route, time
- Right patient Right drug Right dose Right route Right time
Allergy vs Side Effect ME
Allergy
- Immune-mediated reaction
- May preclude re-exposure
Side Effect
- Known pharmacologic effect
- May be manageable
- Document reaction details
Medication Error Response ME
- Error intercepted → Stop process ( Prevent administration )
- Exposure possible → Assess patient ( Stabilize first )
- Harm suspected → Escalate immediately ( Follow emergency protocol )
- Treatment needed → Notify prescriber ( Use verified facts )
- Patient affected → Follow disclosure policy ( Communicate transparently )
- Immediate risk controlled → Report event ( Include near misses )
- Record required → Document objectively ( Avoid blame )
- Review completed → Add system control ( Prevent recurrence )
Medication Safety Controls ME
- Right patient Use two identifiers
- Right drug Verify product and label
- Right dose Calculate and range-check
- Right route Verify form and compatibility
- Right time Check schedule and interactions
- Allergy check Verify before dispensing
- Reconciliation Compare complete medication lists
- High-alert medicine Use independent double-check
- Look-alike names Separate and use Tall Man
- Leading zero Write 0.5 mg
- Trailing zero Never write 5.0 mg
- Oral liquid Use oral syringe
- Near miss Report and analyze
- Barcode Does not replace vigilance
- Medication error Protect patient first
Medication Error vs Adverse Reaction ME
Medication Error
- Preventable process failure
- May cause no harm
Adverse Reaction
- Harmful medicine response
- May occur correctly used
- Classify before reporting
WWHAM Self-Care OT
- Who, what, how long, actions, medicines
- Who is it What symptoms How long Actions tried Medicines used
OTC Triage Picker OT
- Emergency symptoms → Emergency pathway ( Do not delay )
- Serious red flag → Urgent referral ( Avoid masking symptoms )
- Pregnant or breastfeeding → Verify safety ( Consider trimester )
- Very young child → Age-specific pathway ( Check local limits )
- Major comorbidity → Interaction check ( Renal, hepatic, cardiac )
- Duplicate ingredients → Simplify product ( Prevent overdose )
- Mild self-limited problem → Short self-care trial ( Give stop rules )
- Persistent or worsening → Clinical referral ( Reassess diagnosis )
OTC Referral Flags OT
- Chest pain Emergency evaluation
- Severe dyspnea Emergency evaluation
- Anaphylaxis signs Emergency treatment
- GI bleeding signs Urgent referral
- Severe dehydration Urgent referral
- Young infant fever Follow urgent local pathway
- Pregnancy/lactation Verify product safety
- Renal/hepatic disease Check before self-care
- Persistent symptoms Refer for assessment
- Worsening symptoms Stop self-care; refer
- Oral decongestant Caution uncontrolled hypertension
- NSAID Check GI, renal, bleeding risks
- Combination product Check duplicate ingredients
- Self-care advice Give duration and stop rules
Pharmacist vs Clinical Pharmacy LA
Pharmacist
- Code PHO5481
- Pass score 60%
- This sheet's target
Clinical Pharmacy
- Code PHO5482
- Pass score 70%
- Separate DHA assessment
- Match title and code
DHA Licensing Path LA
- Starting application → Self-Assessment Tool ( Check PQR eligibility )
- Credentials accepted → Primary source verification ( DataFlow process )
- CBT required → Prometric assessment ( Use eligibility ID )
- Requirements completed → Get Registered ( DHA reviews application )
- Registration issued → Find licensed facility ( Cannot practice yet )
- Facility hires → Activate license ( Facility completes activation )
- License active → Practice within scope ( Follow DHA requirements )
- Expiry approaches → Renew timely ( Maintain requirements )
UAE Law & Ethics LA
- Dubai regulator Dubai Health Authority
- Practice permission Active professional license
- Registration Eligibility before license activation
- License activation Completed by hiring facility
- Professional scope Stay within licensed activity
- Confidentiality Protect patient information
- Professional duty Accuracy, honesty, patient welfare
- Controlled possession Requires legal authorization
- Controlled dispensing Only legally permitted cases
- Controlled prescription Record on national platform
- Federal law text Original Arabic controls
- Local procedure Follow authority and facility rules
Registration vs Active License LA
Registration
- Confirms title eligibility
- Precedes facility activation
Active License
- Permits professional practice
- Activated by hiring facility
- Registration alone forbids practice
Prescription vs Controlled Medicine LA
Prescription Medicine
- Requires valid prescription
- Standard records apply
Controlled Medicine
- Additional legal restrictions
- National tracking applies
- Controlled rules are stricter
Potency vs Efficacy CL
Potency
- Dose needed
- Reflected by EC50
Efficacy
- Maximum effect
- Reflected by Emax
- More potent is not stronger
Interaction Checker CL
- Two agents flagged → Identify perpetrator ( And affected substrate )
- Concentration changes → PK mechanism ( ADME interaction )
- Effects combine → PD mechanism ( Bleeding, sedation, QT )
- Timing may help → Separate administration ( Only when evidence supports )
- Patient risk high → Avoid combination ( Choose alternative )
- Combination necessary → Monitor or adjust ( Define measurable endpoint )
- Plan selected → Counsel patient ( Give warning signs )
- Action completed → Document rationale ( Arrange follow-up )
Pharmacodynamics Core CL
- Agonist Activates receptor response
- Antagonist Blocks receptor activation
- Partial agonist Lower maximal receptor response
- Potency Dose needed for effect
- Efficacy Maximum achievable effect
- Affinity Binding strength at receptor
- EC50 Concentration producing half-maximal effect
- Competitive antagonist Shifts dose-response right
- Noncompetitive antagonist Lowers maximal effect
- Therapeutic index Toxic dose / effective dose
- Additive effect Combined effects sum
- Synergistic effect Combined effect exceeds sum
- Tolerance Response decreases over time
- Tachyphylaxis Rapidly developing tolerance
Bactericidal vs Bacteriostatic CL
Bactericidal
- Kills susceptible bacteria
- Clinical effect remains context-dependent
Bacteriostatic
- Inhibits bacterial growth
- Host defenses aid clearance
- Label alone never chooses therapy
Clinical Therapy Alerts CL
- ACE inhibitor Cough, hyperkalemia, angioedema
- ACEI pregnancy Contraindicated
- Beta blocker Bradycardia; masks hypoglycemia
- Loop diuretic Hypokalemia and volume depletion
- Spironolactone Hyperkalemia risk
- NSAID GI, renal, fluid risks
- Statin Myopathy and interaction check
- Warfarin INR and interaction monitoring
- DOAC Renal function affects dosing
- Insulin Hypoglycemia risk
- Sulfonylurea Hypoglycemia risk
- Metformin Renal function limits use
- Aminoglycoside Nephrotoxicity and ototoxicity
- Lithium Monitor level, renal, thyroid
- Chronic corticosteroid Do not stop abruptly
- Antimicrobial choice Site, culture, allergy, renal
Common Traps
Invented Blueprint Weights
- DHA lists 14 areas ≠ DHA publishes no percentages
Wrong Pharmacist Code
- PHO5481 is Pharmacist ≠ PHO5482 is Clinical Pharmacy
Score Report Assumption
- Result is Pass/Fail ≠ Numeric score is withheld
Registration Confusion
- Registration confirms eligibility ≠ Active license permits practice
Attempt Rule Confusion
- Maximum three across authorities ≠ No DHA retake grace period
Strength Conversion Error
- 1% w/v = 10 mg/mL ≠ Convert units before calculating
Unsafe Decimal
- Use leading zero ≠ Never use trailing zero
Modified-Release Damage
- Do not crush routinely ≠ Verify product instructions
Glove Substitution
- Gloves reduce exposure ≠ Hand hygiene remains required
Natural Means Safe
- Supplements cause interactions ≠ Always collect supplement history
Allergy Mislabeling
- Allergy is immune-mediated ≠ Side effect may be predictable
Antidote-Only Thinking
- ABCs come first ≠ Supportive care remains essential
Last Minute
- 1. PHO5481 = DHA Pharmacist
- 2. PHO5482 = Clinical Pharmacy
- 3. 150 questions in 3 hours
- 4. PHO5481 pass score is 60%
- 5. Assessment fee is USD 240
- 6. Official coverage has 14 areas
- 7. Domain weights are not published
- 8. Results report Pass/Fail only
- 9. Three attempts across UAE authorities
- 10. No DHA retake grace period
- 11. Registration is not active licensure
- 12. Facility activates professional license
- 13. C1V1 equals C2V2 for dilutions
- 14. Loading dose follows Vd
- 15. Maintenance dose follows clearance
- 16. Steady state needs several half-lives
- 17. Always align calculation units
- 18. Use leading, never trailing zeros
- 19. Gloves never replace hand hygiene
- 20. One syringe serves one patient
- 21. Check renal function before dosing
- 22. Natural products still interact
- 23. OTC red flags require referral
- 24. Poisoning starts with ABCs
- 25. Controlled medicines need stricter records
- 26. Follow current local clinical protocols
DHA Pharmacist Licensing Assessment
- Practice Questions 125 questions Study Guide 63 topics Cheat Sheet 202 facts Flashcards 50 cards Shorts 1 short Podcast
Same family resources
- Explore More Gulf Pharmacist Licensing Exams
- Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
Saudi Pharmacist Licensure Examination (SPLE - Pharmacist)
- Cheat Sheet 83 facts Practice Questions 100 questions Study Guide 42 topics Flashcards 50 cards
Kuwait MOH Licensing Examination - Pharmacist
- Practice Questions 125 questions Shorts 1 short
DOH Abu Dhabi Pharmacist Qualification Exam
- Practice Questions 100 questions
MOHAP Pharmacist Evaluation Exam
- Practice Questions 100 questions
NHRA Licensure Examination - Pharmacist
- Practice Questions 100 questions Shorts 1 short
OMSB Licensing Examination - Pharmacist
- Practice Questions 100 questions